Acro Biomedical (ACBM) Shareholder's Equity Growth (5y) (2020 - 2025)
Acro Biomedical (ACBM) Shareholder's Equity Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.72% |
| Sep 30, 2025 | -20.87% |
| Jun 30, 2025 | -19.02% |
| Mar 31, 2025 | -18.59% |
| Dec 31, 2024 | -18.83% |
| Sep 30, 2024 | -18.40% |
| Jun 30, 2024 | -18.04% |
| Mar 31, 2024 | -17.79% |
| Dec 31, 2023 | -17.29% |
| Sep 30, 2023 | -17.00% |
| Jun 30, 2023 | -15.26% |
| Mar 31, 2023 | -9.07% |
| Dec 31, 2022 | -3.84% |
| Sep 30, 2022 | -0.76% |
| Jun 30, 2022 | 86.25% |
| Mar 31, 2022 | 110.69% |
| Dec 31, 2021 | 98.72% |
| Sep 30, 2021 | 109.56% |
| Jun 30, 2021 | 137.70% |
| Mar 31, 2021 | 136.73% |